VNDA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VNDA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Equity Investments only applies to insurance companies.
Stephen Ray Mitchell | director | C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVE., SUITE 300E, WASHINGTON DC 20037 |
Kevin Patrick Moran | officer: VP, Acting CFO & Treasurer | C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON DC 20037 |
Timothy Williams | officer: SVP & General Counsel | C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE NW, SUITE 300E, WASHINGTON DC 20037 |
Joakim Wijkstrom | officer: SVP, Chief Marketing Officer | 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC DC 20037 |
Mihael Hristos Polymeropoulos | director, officer: Chief Executive Officer | 9605 MEDICAL CENTER DRIVE SUITE 300, ROCKVILLE MD 20850 |
Gunther Birznieks | officer: SVP, Business Development | 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON DC 20037 |
Tage Honore | director | C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON DC 20037 |
Thomas Watkins | director | 1221 GULF SHORE BLVD N #303, NAPLES FL 34102 |
Aranthan Ii Jones | officer: Chief Corp. Affairs Officer | 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON DC DC 20037 |
Phaedra Chrousos | director | 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON DC 20037 |
Richard W Dugan | director | 20425 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876 |
James Patrick Kelly | officer: SVP, CFO, Treasurer & Secretar | C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE, ROCKVILLE MD 20850 |
Gian Piero Reverberi | officer: SVP, General Manager Europe | 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON DC 20037 |
Anne Sempowski Ward | director | C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON DC 20037 |
Vincent Milano | director | C/O VIROPHARMA INC, 405 EAGLEVIEW BLVD, EXTON PA 19341 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.